Treatment with bezuclastinib plus Sutent led to safe and efficacious outcomes versus Sutent treatment alone in gastrointestinal stromal tumors.
EXUMA now advancing its clinically de-risked solid tumor & hematologic CARs with in vivo GCAR â„¢ platform and SCL mRNA technology WEST PALM BEACH, FL, USA I3, 2025 I EXUMA Biotech, Corp., a ...
In the words of the great James Worthy, the Lakers went out and got that Celtics a-- and boy did it feel good. Nothing fixes ...